Mesenchymal  	Mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
for  	for  	 IN	O
acute  	acute  	 JJ	O
lung  	lung  	 NN	B-NP
injury 	injury 	 NN	I-NP
:  	:  	 :	O
preclinical  	preclinical  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
Several  	Several  	 JJ	O
experimental  	experimental  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
suggested  	suggested  	 VBN	O
that  	that  	 IN	O
mesenchymal  	mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
may  	may  	 MD	O
have  	have  	 VB	O
value  	value  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
myocardial  	myocardial  	 JJ	B-NP
infarction 	infarction 	 NN	I-NP
,  	,  	 ,	O
diabetes 	diabetes 	 NN	O
,  	,  	 ,	O
acute  	acute  	 JJ	O
renal  	renal  	 JJ	B-NP
failure 	failure 	 NN	I-NP
,  	,  	 ,	O
sepsis 	sepsis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
acute  	acute  	 JJ	O
lung  	lung  	 NN	B-NP
injury 	injury 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
preclinical  	preclinical  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
mesenchymal  	mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
reducing  	reducing  	 VBG	B-NP
lung  	lung  	 NN	I-NP
injury  	injury  	 NN	I-NP
from  	from  	 IN	O
endotoxin 	endotoxin 	 NN	B-NP
,  	,  	 ,	O
live  	live  	 JJ	O
bacteria 	bacteria 	 NNS	O
,  	,  	 ,	O
bleomycin 	bleomycin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
hyperoxia 	hyperoxia 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
cultured  	cultured  	 JJ	O
medium  	medium  	 NN	O
from  	from  	 IN	O
mesenchymal  	mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
as  	as  	 IN	O
effective  	effective  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
mesenchymal  	mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
themselves 	themselves 	 PRP	O
.  	.  	 .	O
Several  	Several  	 JJ	O
paracrine  	paracrine  	 JJ	B-NP
mediators  	mediators  	 NNS	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
mediate  	mediate  	 VB	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
mesenchymal  	mesenchymal  	 JJ	B-NP
stem  	stem  	 NN	I-NP
cells  	cells  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
identified 	identified 	 VBN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
interleukin-10 	interleukin-10 	 NNP	I-NP
,  	,  	 ,	O
interleukin-1ra 	interleukin-1ra 	 NNP	B-NP
,  	,  	 ,	O
keratinocyte  	keratinocyte  	 JJ	B-NP
growth  	growth  	 NN	I-NP
factor 	factor 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
prostaglandin  	prostaglandin  	 JJ	B-NP
E2 	E2 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 RBR	O
preclinical  	preclinical  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
needed 	needed 	 VBN	O
,  	,  	 ,	O
as  	as  	 RB	O
is  	is  	 VBZ	O
planning  	planning  	 VBG	O
for  	for  	 IN	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
for  	for  	 IN	O
acute  	acute  	 JJ	O
lung  	lung  	 NN	B-NP
injury 	injury 	 NN	I-NP
.  	.  	 .	O
